29.04.2016
- As expected, French drugmaker Sanofi has made an unsolicited all cash, non-binding proposal bid to acquire US biopharmaceuticals firm Medivation. In a letter to the board of the...
27.04.2016
- US regulators have given a breakthrough designation to Bristol-Myers Squibb’s cancer drug Opdivo (nivolumab) for treating head and neck cancer. This is the fifth breakthrough...
22.04.2016
- US drugmaker Merck has gained Breakthrough Therapy Designation (BTD) from the US Food and Drug Administration (FDA) for Keytruda to treat patients with classical Hodgkin lymphoma...
14.04.2016
- Bristol-Myers Squibb’s cancer drug Opdivo can now be used to treat more patients with lung cancer or kidney cancer after European regulators expanded its indications. The EU...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
29.03.2016
- French drug maker Sanofi has appointed Dr. Yong-Jun Liu, one of the world's most prolific researchers in immunology, as Head of Research, Global R&D, effective April 1, 2016. Dr...
24.02.2016
- Austrian biotech firm OncoQR ML has cleared an important hurdle toward producing a vaccine against pancreatic cancer. In a preclinical trial of what it termed “a highly relevant...
10.02.2016
- The combination of two cancer drugs from UK-Swedish drugs maker AstraZeneca and its biologics research and development arm MedImmune could be a potential breakthrough in treating a...
